Six institutions have joined in the creation of the Massachusetts Alzheimer's Disease Research Center (ADRC): four Harvard- affiliated hospitals (Massachusetts General, Brigham and Women's, Beth Israel, and McLean Hospitals); the University of Massachusetts Medical Center; and Massachusetts Institute of Technology. This regional consortium unites a large group of researchers and clinicians with established and potential interests in Alzheimer's disease (AD); it capitalizes on formalized interactions and focuses efforts on improving the diagnosis, understanding the basic mechanisms, and developing treatments for AD. By creating a research capacity and collective intelligence that exceeds the sum of its parts, the Center stimulates investigations b the exchange of ideas, techniques, and experience. A Clinical Core comprising units at MGH, BIH, and UMMC has been established to enroll, diagnose, and follow patients with dementia, provide a pool of patients for clinical investigation, and to collect systematic clinical data regarding the features of AD. A Data Management Core has been established to store information on all patients in the clinical units and all postmortem examinations; personnel in this Core also assist in protocol design and statistical analyses. A Neuropathology Core establishes diagnoses on all brains obtained, and operates a brain bank, storing tissue of AD patients suitable for chemical, histologic, histochemical, and immunocytochemical studies. Research projects examine major issues in AD: new diagnostic methods; reliable information on clinical course; genetic and biochemical aspects of its etiology; the identity and quantity of neural elements affected; and the biologic basis of clinical manifestations. Through the Harvard Geriatric Educational Center, professional training and continuing medical education programs have been expanded. Quarterly workshops on topics of fundamental neurobiological importance are planned with visiting scientists to exchange ideas with ADRC members.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Specialized Center (P50)
Project #
5P50AG005134-04
Application #
3104746
Study Section
Aging Review Committee (AGE)
Project Start
1984-09-28
Project End
1989-08-31
Budget Start
1987-07-01
Budget End
1988-06-30
Support Year
4
Fiscal Year
1987
Total Cost
Indirect Cost
Name
Harvard University
Department
Type
Schools of Medicine
DUNS #
082359691
City
Boston
State
MA
Country
United States
Zip Code
02115
Kamara, Dennis M; Gangishetti, Umesh; Gearing, Marla et al. (2018) Cerebral Amyloid Angiopathy: Similarity in African-Americans and Caucasians with Alzheimer's Disease. J Alzheimers Dis 62:1815-1826
Brent, Robert J (2018) Estimating the monetary benefits of medicare eligibility for reducing the symptoms of dementia. Appl Econ 50:6327-6340
Wegmann, Susanne; Eftekharzadeh, Bahareh; Tepper, Katharina et al. (2018) Tau protein liquid-liquid phase separation can initiate tau aggregation. EMBO J 37:
Racine, Annie M; Brickhouse, Michael; Wolk, David A et al. (2018) The personalized Alzheimer's disease cortical thickness index predicts likely pathology and clinical progression in mild cognitive impairment. Alzheimers Dement (Amst) 10:301-310
Bennett, Rachel E; Robbins, Ashley B; Hu, Miwei et al. (2018) Tau induces blood vessel abnormalities and angiogenesis-related gene expression in P301L transgenic mice and human Alzheimer's disease. Proc Natl Acad Sci U S A 115:E1289-E1298
Deming, Yuetiva; Dumitrescu, Logan; Barnes, Lisa L et al. (2018) Sex-specific genetic predictors of Alzheimer's disease biomarkers. Acta Neuropathol 136:857-872
Kaur, Antarpreet; Edland, Steven D; Peavy, Guerry M (2018) The MoCA-Memory Index Score: An Efficient Alternative to Paragraph Recall for the Detection of Amnestic Mild Cognitive Impairment. Alzheimer Dis Assoc Disord 32:120-124
Tse, Kai-Hei; Cheng, Aifang; Ma, Fulin et al. (2018) DNA damage-associated oligodendrocyte degeneration precedes amyloid pathology and contributes to Alzheimer's disease and dementia. Alzheimers Dement 14:664-679
Lee, Catherine; Betensky, Rebecca A; Alzheimer's Disease Neuroimaging Initiative (2018) Time-to-event data with time-varying biomarkers measured only at study entry, with applications to Alzheimer's disease. Stat Med 37:914-932
Schaffert, Jeff; LoBue, Christian; White, Charles L et al. (2018) Traumatic brain injury history is associated with an earlier age of dementia onset in autopsy-confirmed Alzheimer's disease. Neuropsychology 32:410-416

Showing the most recent 10 out of 966 publications